A 54-year-old ultra-marathon runner who had breast cancer says it is her ultimate ambition to complete the 100 Marathon Club ...
Results showed lasofoxifene protected against hormone withdrawal-induced bone loss and maintained a robust anti-tumor response in primary and metastatic animal models of ER+ breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results